Artificial Intelligence in Oncology Market Size and Share - Growth Analysis Report and Forecast Trends (2026-2035)

The global artificial intelligence in oncology market was valued at USD 3.23 Billion in 2025. It is poised to grow at a CAGR of 28.60% during the forecast period of 2026-2035, and reach USD 39.96 Billion by 2035. The market growth is driven by the rising cancer burden, growing adoption of precision medicine, and advancements in AI technologies.

Key Market Trends and Insights

• Based on offerings, the hardware segment led the market with the largest revenue share of above 39% during the historical period.
• Based on cancer type, the breast cancer segment dominated the market, accounting for more than 20% revenue share during the historical period.
• North America held the dominant position in the market, capturing approximately 45% of the total revenue during the historical period.

Market Size and Forecast

• Market Size (2025): USD 3.23 Billion
• Projected Market Size (2035): USD 39.96 Billion
• CAGR (2026-2035): 28.60%

Q1 2026 Market Updates

Overview: For companies and buyers tracking the Artificial Intelligence In Oncology sector, Q1 2026 was a quarter unlike any recent precedent. Demand signals for the global artificial intelligence in oncology market through healthcare system stress-testing, defense medical digitalization, and the validation of remote care and AI-enabled health technology under conflict-proximate conditions. Conflict-driven healthcare system overload, with Israeli hospitals managing exceptional casualty volumes and Gulf state healthcare systems maintaining continuity during regional uncertainty, proved out the operational importance of digital health platforms, AI clinical decision support, and remote patient monitoring technology. Shield AI's defense AI validation (Shield AI reaching a $12.7 billion valuation (CNBC, March 28, 2026)) and Palantir Maven's deployment (Palantir Maven AI deployed by US and allied forces (Alex Karp, CNBC, March 28, 2026)) reinforce the broader AI technology investment environment that is accelerating AI adoption in healthcare settings.

United States: Looking at the US specifically, Looking at the US market specifically, US artificial intelligence in oncology market demand over Q1 2026 was elevated by defense healthcare digitalization, with military medical facilities adopting advanced clinical IT, AI decision support, and telemedicine platforms to manage elevated caseload from Q1 2026 military operations. US hospital systems invested in cyber security hardening for health IT infrastructure, with Q1 2026 conflict-adjacent cyber threat environment motivating healthcare cyber security investment acceleration. US healthcare AI investment, with companies like Tempus, Veracyte, and emerging AI health startups attracting elevated funding, was reinforced by Q1 2026's validation of AI-enabled decision-making in high-pressure environments. CMS reimbursement expansion for digital health services maintained commercial adoption momentum independent of Q1 2026 disruption.

Iran & Israel: Israel's digital health sector, one of the world's most advanced per-capita medtech ecosystems, demonstrated operational resilience throughout Q1 2026, with health IT systems, telemedicine platforms, and AI diagnostic tools maintaining functionality under conflict-proximate conditions. Israeli digital health companies, including Zebra Medical Vision, MedAware, and dozens of AI diagnostics startups, continued operations and attracted investor attention as conflict proved out the operational value of AI-enabled clinical tools. Gulf state digital health investment, Vision 2030 healthcare digitalization and UAE's Smart Dubai health platform programs, maintained procurement of artificial intelligence in oncology market platforms supported by elevated oil revenues from Brent crude at USD 126/barrel (Wikipedia). Iran's healthcare IT infrastructure, already severely constrained by international software and technology sanctions, faced additional Q1 2026 disruption to digital health capability maintenance.

Key Takeaways

Government & Policy Watch

• Defense healthcare IT: US military medical facility digital health investment is elevated by Q1 2026 operational demands, with AI clinical decision support, telemedicine, and healthcare cyber security receiving accelerated procurement authorization.
• Cyber security investment: Q1 2026 elevated cyber threat environment is accelerating healthcare IT security investment, with hospital systems hardening EHR, medical device, and health analytics infrastructure against state-sponsored cyber attack.
• AI validation: Q1 2026 AI system validation at scale, Shield AI's $12.7B valuation and Palantir Maven deployment, reinforces healthcare investor confidence in AI platform investment across clinical decision support and diagnostics applications.

Market & Industry Impact

• Market growth: The artificial intelligence in oncology market is growing on AI adoption, cloud migration, interoperability mandates, remote care expansion, and value-based care data requirements, with Q1 2026 providing near-term defense healthcare IT demand acceleration.
• AI in clinical care: AI-enabled clinical decision support, medical imaging analysis, and predictive patient monitoring are one of the faster-growing artificial intelligence in oncology market segments, with large language model integration creating new capability dimensions.
• Telehealth permanence: Post-pandemic telehealth permanence, reinforced by Q1 2026 remote care operational validation, continues to drive digital health platform investment across outpatient, chronic care, and mental health service delivery.

Procurement & Supply Chain Alert

• Cyber security risk: Healthcare IT systems represent high-value cyber attack targets, with Q1 2026 conflict-adjacent state-sponsored cyber threat environment creating elevated ransomware, data breach, and system disruption risk for health IT operators.
• Interoperability complexity: Artificial intelligence in oncology market system integration with legacy EHR, medical device, and administrative systems requires extensive API development and data standardization investment, a technical barrier that constrains rapid deployment.
• Regulatory compliance: Digital health products face FDA Software as a Medical Device (SaMD) regulation, HIPAA privacy requirements, and ONC interoperability rules, a multi-framework compliance environment that adds cost and timeline to product development.